NAD+ is one of the most heavily marketed longevity interventions in telehealth right now. Here's the honest picture: strong animal data, a real and measurable age-related decline in humans, and clinical translation that researchers themselves say is still an active area of investigation — not a settled question.
"As a hypothesis, as an idea, it's very attractive. But we are still in the early stages of human studies and the health benefits of augmenting NAD+ are yet to be established in large human studies." — Dr. Shalender Bhasin, Boston Pepper Aging Research Center, Brigham and Women's Hospital
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in hundreds of metabolic processes — cellular energy production, DNA repair pathways, and sirtuin activity, the proteins implicated in cellular aging regulation. Research published in Nature Reviews Molecular Cell Biology has documented that NAD+ levels measurably decline with age, and this decline correlates with changes in mitochondrial function and metabolic regulation. That part of the story is not controversial — it's well-replicated science.
It's also well-established that supplementation with NAD+ precursors can raise circulating NAD+ metabolite levels. The biochemistry works as described.
The gap is between "NAD+ levels can be raised" and "raising NAD+ levels produces specific, reliable anti-aging health outcomes in humans." Most of the dramatic findings — improved mitochondrial health, increased strength and exercise performance, decreased inflammation — come from animal models, primarily mice. Dr. Bhasin's assessment, echoed throughout 2026 reporting including NPR's coverage of the field, is that this preclinical excitement has not yet been matched by large, rigorous human trials.
A 2026 PRISMA-guided systematic review analyzing 80 rodent studies alongside 33 human studies reached a clear conclusion: biological activity is clear, but clinical effectiveness for anti-aging in humans remains inconclusive. The review specifically flagged the translation problem — NAD+ metabolism differs meaningfully between animal models and humans, making direct extrapolation unreliable.
This is worth sitting with: the delivery method most aggressively marketed as premium (IV infusion) currently has the weakest direct clinical evidence behind it, while the less glamorous oral route has comparatively more (though still limited) human data. Marketing intensity and evidence strength are not tracking together in this space.
A theoretical concern exists because NAD+ augmentation could plausibly support cell proliferation pathways relevant to cancer biology. The current clinical consensus, as of 2026, is that there is no definitive human evidence that NAD+ supplementation causes cancer in healthy individuals — but researchers note the theoretical risk is sufficient that people with a personal or family history of cancer should have an explicit, informed conversation with an oncology-aware physician before starting any NAD+ protocol. This isn't a reason for panic; it's a reason for disclosure and informed conversation, which any legitimate telehealth provider should be having with you directly.
| Consideration | Honest assessment |
|---|---|
| If you want guaranteed anti-aging outcomes | Not currently supported by human RCT evidence |
| If you're curious about an emerging, biologically plausible intervention | Reasonable, with appropriate expectations |
| If choosing between oral and IV delivery | Oral has comparatively more (though still limited) human evidence |
| If you have a cancer history | Discuss explicitly with an oncology-informed physician first |
NAD+ therapy sits in a genuinely interesting scientific space — real, replicated basic science about age-related decline, combined with clinical translation that hasn't caught up yet. That's not the same as "it doesn't work," and it's not the same as "it's proven to work" either. The honest position, shared by researchers actively working in this field, is that this is a legitimate area of ongoing investigation with biological plausibility, not yet a settled anti-aging treatment with guaranteed outcomes. Anyone considering it should go in with that calibrated expectation — and should work with a provider who discusses the evidence honestly rather than overselling certainty that doesn't yet exist.
AgelessRx provides physician-supervised NAD+ injection therapy with proper clinical oversight and individualized dosing — at a fraction of IV clinic pricing.
Learn more at AgelessRx →